furosemide has been researched along with dipyridamole in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (35.48) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 12 (38.71) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Mustard, JF; Packham, MA | 1 |
| Gould, KL; Hamilton, GW; Narahara, KA; Ritchie, JL; Williams, DL; Yee, H | 1 |
| Higuchi, M; Itoh, N; Miyasaka, M; Moriya, T; Nakazawa, K; Oguchi, H; Shigematsu, H | 1 |
| Scheidler, K; Weser, C | 1 |
| Askari, A; Rao, SN | 1 |
| Cummings, YE; Dillard, MG | 1 |
| Deuticke, B; Gerlach, E | 1 |
| Burke, W; DePace, NL; Glazier, EE; Kotler, MN | 1 |
| Djukanović, Lj; Ikonomovski, J; Milovanović, D | 1 |
| Bakhle, YS; Patel, K | 1 |
| Etoh, A; Kohno, K | 1 |
| Berliner, S; Pinkhas, J; Shaklai, M; Shoenfeld, Y | 1 |
| Bernhardt, I; Bogdanova, AY; Ellory, JC; Hamann, J; Kiessling, K; Kummerow, D | 1 |
| Aktaş, A; Atar, I; Aydinalp, A; Bal, U; Ertan, C; Haberal, M; Mudderisoglu, H; Ozin, B; Yildirir, A | 1 |
| Basit, AW; Flanagan, T; Martin, PD; Rabbie, SC | 1 |
| Souvannamethy, P | 1 |
| Deng, H; Du, M; Fu, J; Liu, R; Wan, H; Wang, X; Zhang, Y | 1 |
3 review(s) available for furosemide and dipyridamole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
28 other study(ies) available for furosemide and dipyridamole
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Myocardial imaging with thallium-201: effect of cardiac drugs on myocardial images and absolute tissue distribution.
Topics: Animals; Digoxin; Dipyridamole; Dogs; Furosemide; Heart; Myocardium; Propranolol; Radioisotopes; Radionuclide Imaging; Thallium; Tissue Distribution | 1978 |
A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Topics: Adolescent; Basement Membrane; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Furosemide; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Kidney Glomerulus; Prednisolone; Warfarin | 1992 |
[Differential treatment of coronary heart disease].
Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; Humans; Lidocaine; Methods; Myocardial Infarction; Nitroglycerin; Pentaerythritol Tetranitrate; Prenylamine; Propranolol | 1974 |
Drugs affecting sodium transport in human erythrocyte ghosts.
Topics: Acetates; Adenosine Triphosphatases; Anesthetics, Local; Biological Transport, Active; Cell Membrane; Chlorpromazine; Desipramine; Dipyridamole; Erythrocytes; Ethacrynic Acid; Furosemide; Humans; Imipramine; Iodine; Lactates; Oligomycins; Ouabain; Potassium; Pyruvates; Sodium | 1970 |
Treatment of malignant hypertension. The influence of etiology on the survival in 12 consecutive patients.
Topics: Adult; Antihypertensive Agents; Diet, Sodium-Restricted; Dipyridamole; Female; Furosemide; Heparin; Humans; Hypertension, Malignant; Kidney Diseases; Male; Peritoneal Dialysis; Prognosis; Renal Dialysis | 1974 |
[The influencing of human erythrocyte form and phosphate permeability using hemolysins, benzene derivatives and pharmacologically active substances].
Topics: Anesthetics, Local; Benzene Derivatives; Cell Membrane Permeability; Detergents; Dipyridamole; Erythrocytes; Fatty Acids; Furosemide; Hemolysin Proteins; Humans; In Vitro Techniques; Phlorhizin; Phosphates | 1967 |
An unusual case of Bjork-Shiley mitral valve dysfunction corrected nonsurgically.
Topics: Aspirin; Cardiomegaly; Dipyridamole; Echocardiography; Female; Furosemide; Heart Murmurs; Heart Valve Prosthesis; Humans; Hypotension; Middle Aged; Mitral Valve Prolapse; Phenylephrine; Prothrombin Time; Warfarin | 1981 |
[The effect of drugs on peritoneal dialysis clearance].
Topics: Aminophylline; Creatinine; Dipyridamole; Furosemide; Humans; Kidney Failure, Chronic; Nitroprusside; Peritoneal Dialysis; Peritoneum; Urea | 1984 |
Thromboxane B2 (TxB2) metabolism in rat isolated lung and its inhibition by drugs.
Topics: Animals; Bromcresol Green; Dinoprostone; Dipyridamole; Furosemide; In Vitro Techniques; Lung; Male; Perfusion; Prostaglandins E; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxanes | 1983 |
[Interactions by diltiazem (4). Relationship between first pass metabolism of various drugs and absorption enhancement by diltiazem].
Topics: Animals; Benzazepines; Biological Availability; Diltiazem; Dipyridamole; Dogs; Drug Interactions; Furosemide; Humans; Male; Middle Aged; Pharmaceutical Preparations | 1983 |
Conservative treatment of Budd-Chiari syndrome in polycythemia vera.
Topics: Aspirin; Budd-Chiari Syndrome; Busulfan; Dipyridamole; Female; Furosemide; Humans; Leukapheresis; Middle Aged; Polycythemia Vera | 1981 |
Characterization of the K+ (Na+)/H+ monovalent cation exchanger in the human red blood cell membrane: effects of transport inhibitors.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Carboxylic Acids; Dipyridamole; Diuretics; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythrocyte Membrane; Furosemide; Humans; Indans; Indenes; Mitochondria; Potassium Channel Blockers; Potassium Channels; Quinacrine; Reference Values; Sodium-Hydrogen Exchangers | 1999 |
Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Artery Disease; Dipyridamole; Exercise Test; Female; Furosemide; Humans; Liver Transplantation; Male; Preoperative Care; Risk Factors; Thallium; Tomography, Emission-Computed, Single-Photon | 2009 |
Inter-subject variability in intestinal drug solubility.
Topics: Administration, Oral; Biological Availability; Buffers; Colitis, Ulcerative; Dipyridamole; Furosemide; Humans; Hydrogen-Ion Concentration; Ileostomy; Intestinal Absorption; Intestinal Secretions; Models, Biological; Solubility | 2015 |
Management of Nephrotic Syndrome: A Case Report from Lao PDR.
Topics: Adult; Albumins; Dipyridamole; Female; Furosemide; Humans; Iron; Laos; Methylprednisolone; Nephrotic Syndrome | 2017 |
Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report.
Topics: Aspirin; Capillary Leak Syndrome; Dipyridamole; Diuretics; Furosemide; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Male; Mannitol; Meningitis, Aseptic; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Serum Albumin, Human | 2018 |